ATE305784T1 - Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain - Google Patents

Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain

Info

Publication number
ATE305784T1
ATE305784T1 AT00911804T AT00911804T ATE305784T1 AT E305784 T1 ATE305784 T1 AT E305784T1 AT 00911804 T AT00911804 T AT 00911804T AT 00911804 T AT00911804 T AT 00911804T AT E305784 T1 ATE305784 T1 AT E305784T1
Authority
AT
Austria
Prior art keywords
premenstrual syndrome
lidocain
dysmenorrhea
medicine
dysmenorrhoea
Prior art date
Application number
AT00911804T
Other languages
English (en)
Inventor
Greta Edelstam
Original Assignee
Edelstam Inc
Greta Edelstam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/800,737 external-priority patent/US5977143A/en
Application filed by Edelstam Inc, Greta Edelstam filed Critical Edelstam Inc
Application granted granted Critical
Publication of ATE305784T1 publication Critical patent/ATE305784T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT00911804T 1997-02-15 2000-02-12 Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain ATE305784T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/800,737 US5977143A (en) 1997-02-15 1997-02-15 Medicament against infertility which reduces phagocytosis of spermatozoa in women
US26550299A 1999-03-10 1999-03-10
PCT/US2000/003782 WO2000053183A1 (en) 1997-02-15 2000-02-12 Medicament against dysmenorrhoea and premenstrual syndrome

Publications (1)

Publication Number Publication Date
ATE305784T1 true ATE305784T1 (de) 2005-10-15

Family

ID=26951241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911804T ATE305784T1 (de) 1997-02-15 2000-02-12 Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain

Country Status (8)

Country Link
US (2) US6716446B2 (de)
EP (1) EP1158978B1 (de)
AT (1) ATE305784T1 (de)
AU (1) AU774046B2 (de)
CA (1) CA2364470A1 (de)
ES (1) ES2249250T3 (de)
NO (1) NO323693B1 (de)
WO (1) WO2000053183A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774046B2 (en) * 1997-02-15 2004-06-17 Edelstam Inc. Medicament against dysmenorrhoea and premenstrual syndrome
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20040142968A1 (en) * 2003-01-17 2004-07-22 Donald Price Method and kit for treating lower bowel pain
EP1644705B1 (de) * 2003-06-24 2016-10-12 Cidra Corporate Services, Inc. System und verfahren zum betreiben eines flussprozesses
WO2010099508A1 (en) * 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2011145993A1 (en) * 2010-05-19 2011-11-24 Isifer Ab Treatment for reducing inflammation
US9440671B2 (en) * 2012-09-20 2016-09-13 Polaris Industries Inc. Vehicle
AU2014374361B9 (en) 2013-12-31 2019-07-04 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
CA3002515C (en) * 2015-10-23 2024-01-02 Isifer Ab Composition for treatment of infertility in a female subject

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964563A (en) * 1975-01-29 1976-06-22 Allen Carling D Wheel-support structure in vehicles
US4207891A (en) * 1978-10-10 1980-06-17 Population Research Incorporated Dispensing instrument with supported balloon
US4780480A (en) * 1983-07-14 1988-10-25 Syntex (U.S.A.) Inc. Aroyl benzofuran and benzothiophene acetic and propionic acids
US5534242A (en) * 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
US5977143A (en) * 1997-02-15 1999-11-02 Edelstam; Greta Medicament against infertility which reduces phagocytosis of spermatozoa in women
AU774046B2 (en) * 1997-02-15 2004-06-17 Edelstam Inc. Medicament against dysmenorrhoea and premenstrual syndrome
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
CN102344460B (zh) 2002-11-15 2014-05-28 哈佛学院院长等 使用脒基金属的原子层沉积

Also Published As

Publication number Publication date
NO20014361D0 (no) 2001-09-07
EP1158978A4 (de) 2004-03-17
US6835388B2 (en) 2004-12-28
AU3363700A (en) 2000-09-28
EP1158978B1 (de) 2005-10-05
US20030004213A1 (en) 2003-01-02
US6716446B2 (en) 2004-04-06
US20030008916A1 (en) 2003-01-09
CA2364470A1 (en) 2000-09-14
WO2000053183A1 (en) 2000-09-14
ES2249250T3 (es) 2006-04-01
AU774046B2 (en) 2004-06-17
NO323693B1 (no) 2007-06-25
EP1158978A1 (de) 2001-12-05
NO20014361L (no) 2001-11-02

Similar Documents

Publication Publication Date Title
BG106906A (bg) Пуринови производни
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
AR012417A1 (es) COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.
DK0490944T3 (da) Transmucosal doseringsform
MY119365A (en) Novel pharmaceutical combination
JP2005533021A5 (de)
NO920740D0 (no) Doseringsform for oral administrering av hypoglykemisk glipizid
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
NO20014361L (no) Medikament mot dysmenorrhea og premenstruelt syndrom
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
IS4251A (is) Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
IS5152A (is) Lyf gegn ófrjósemi og til að auka frjósemi
HUP0004461A2 (hu) Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények
KR960700701A (ko) 파라세타몰 및 l-시스테인 또는 이것의 전구물질을 함유하는 약제조성물(pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof)
SE0102887D0 (sv) New formulation
JP2025522146A5 (de)
CA2494569A1 (en) An analgesic agent for newborn or fetal subjects
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties